Summary
Lymphedema is one of the most common complications after breast cancer treatment. It is an important problem that affects individuals" lifestyles and functions, causing physical and psychosocial problems, and affecting quality of life negatively. The treatment of lymphedema was thought to be impossible in the past but it has now become possible to manage the condition more effectively with current treatment methods. Nurses, who are important members of the healthcare team, play a key role in helping patients to take their own responsibility for lymphedema, in the prevention, management and follow up of lymphedema. Nurses should be able to identify the group of patients at high risk for developing lymphedema, provide the necessary training for lymphedema prevention, evaluate lymphedema to prevent it and plan for appropriate nursing interventions in the early process. This literature review aims to inform nurses and other healthcare professions about lymphedema management.Introduction
Breast cancer (BC) is one of the most common types of cancer among women in the world and it is held responsible for 25% of all cancer and 15% cancer-related deaths.[1] In parallel with this increase in its incidence, pathogenesis of BC has been understood at the present time and under favor of advanced technology highly effective improvements have been made progress in BC treatment. Treatment methods of BC are surgery, chemotherapy, radiotherapy and hormonal therapy. One or more these treatment methods can be used in the treatment of patients according to their individual characteristics and status of disease. While these methods extend life span, they bring along some complications that negatively affect quality of life.[2-4] Lymphedema is one of the most common postoperative complication, especially after BC surgery, it has been defined as an abnormal accumulation of protein-rich fluid in the interstitial space as a result of impaired lymphatic function due to axillary lymph node dissection, radiotherapy, fibrosis or inflammation.[2-6] Due to the differences in the diagnostic and assessment methods and the range of follow-up of patients, the incidence of breast cancer-related lymphedema (BCRL) is not known precisely.[7-11] While the exact incidence of lymphedema is unknown, the incidence of lymphedema is reported in the studies that show a wide range, such as 6-83%.[2,12-14] The reason of this wide range is due to the fact different grading scales and symptom assessment tools were being used. Further, because the use of patient-reported outcome measures and/or objective assessments result in a higher severity of BCRL as compared to clinician examination, it is thought that BCRL is typically underreported. Also lymphedema is an important complication that may ensue BC treatment in one out of every four women (25%).[12,13,15]
Classification and Staging of Lymphedema
Although there are numerous international classification
and staging initiatives for lymphedema, there is
no single method that provides a comprehensive view
of the etiopathogenesis of lymphedema or important
overlaps between lymphedema grades.[16]
Classification
Lymphedema classification is not a staging technique.
Classification is divided into two groups according to
lymphedema etiology; idiopathic/primary or acquired/
secondary lymphedema.[16-21]
Primary lymphedema develops due to congenital dysfunction or malformation of the lymphatic system and it is not associated with any injury, trauma, illness and treatment.[17-21] Primary lymphedema is divided into different groups according to clinical indications which are age-related situations:
1. Congenital lymphedema; occurs present at or
shortly after birth
Secondary lymphedema occurs as a result of obstruction
and/or loss of normal lymphatic flow and obstruction
of lymphatic channels due to surgical intervention,
radiation therapy, trauma, infection, inflammation (Table
1).[19,23-25] Secondary lymphedema is more common
than primary lymphedema and ensues BC treatment
in the majority of developed countries.[16-24]
Table 1: Causes of secondary lymphedema
Staging
According to this report, ISL has staged lymphedema
in 4 steps (Table 2):[16,19,20,24,26-30]
The severity of each stage is based on the volume
differences between the extremities. It is stated that an
increase of less than 20% in the extremity volume is
minimal, an increase of 20% to 40% is moderate, and
an increase of 40% is severe lymphedema. All these stages only indicate the physical condition of the extremities.[16,19,20,24,26-29]
Lymphedema Risk Factors
Table 3: Lymphedema risk factors
A number of treatment modalities, such as the more
extensive and aggressive treatments, are reported to
pose a risk in the development of lymphedema. Within
these factors, axillary lymph node dissection (ALND)
is one of the most important risk factor. Compared to
sentinel lymph node dissection, it increases the risk of
lymphedema fourfold. In addition to these factors it is
indicated that especially large breast surgery, combined
radiotherapy and chemotherapy regimens also increase
the risk of lymphedema.[11,13,30-34]
Patient-related factors include age, overweight or
obesity, hypertension, physical activity level, comorbid
conditions.[35-37]
It is indicated that factors associated with the disease
are tumor progression, localization, size, and
lymph node involvement.[38,39]
Signs and Symptoms of Lymphedema
• Sensation of heaviness and tightness on the affected
extremity
Sackey et al. (2014) found that 74.2% of patients
with invasive breast cancer, pathologic lymph node involvement
and ALND had early signs of lymphatic insufficiency (heaviness, pain, fatigue and tightness) after
one year of surgery.[43]
Lymphedema Diagnosis and Assessment Methods
Anamnesis (Patient History)
For the health condition, data such as time of BC
diagnosis, the presence of the disease on the same side
as the active arm, infection history, applied surgical
method, axillary dissection, number of excised lymph
nodes, axillary radiotherapy postoperative period and
cardiovascular diseases should be taken.[3,5,45]
Physical Examination
With inspection; skin color, folds and tags, scar
and incision trace, moisture, integrity are assessed. In purpalpation;
skin temperature, thickness, moisture, mobility,
pitting edema, pulse and senses are also considered.[46,47]
Upper Extremity Circumference Measurements
Volumetric Measurements
Imaging Methods
Lymphedema Management
Lymphedema, which is thought to be impossible
in the past, can be treated more effectively with some
methods currently developed.[52] Nevertheless, the
prevention of lymphedema development is easier, more
effective and more important than treatment after it
has developed. The recommended treatment modalities
for controlling symptoms of lymphedema, increasing
functional capacity, reducing complications, and
treating lymphedema when it develops can be treated
under the title of conservative (non-surgical) and surgical
treatment.[50,53] Conservative treatment consists
of physical therapy and medical treatment. Physical
therapy includes implementations such as complete
decongestive therapy (CDT), pneumatic compression
pumps, low level laser therapy, kinesio taping.[2,53-
Table 4: Two phased complete decongestive therapy
Skin and Nail Care
Patients who are at risk for lymphedema should
be thoroughly informed of their proper cleaning and
moisturizing methods.[15,60] In the course of patient
education, methods of evaluation of infection and inflammation
should be explained in detail. At the beginning
of the treatment, the patient should be given a
checklist to indicate the activities that should be avoided,
which may lead to lymphedema.[60]
Compression Treatment
Compression bandages
Compression garments
Compression devices
Compression devices should not be used in case
of congestive heart failure, known or suspected deep
vein thrombosis or pulmonary embolism, active erysipelas
or cellulitis, ischemic vascular disease, severe
peripheral neuropathy, edema on the proximal limb of
the extremity, active metastatic disease on the affected
limb, as it would increase venous return with lymphatic
transport.[3,
Manual Lymphatic Drainage (MLD)
The aims of treatment are to reduce lymphedema
by increasing lymphatic drainage, to prevent tissue fibrosis
and the development of lymphedema again.[45]
Simple Lymphatic Drainage/ Self Lymphatic
Drainage (SLD
Points to take into consideration when performing
SLD can be summarized as follows:
• Supporting the affected extremity with a pillow or
roller and placement of the shoulder in a comfortable
area/table
Physical Activity and Exercise
Exercise and the maintenance of ideal body weight
are especially important for breast cancer patients. Because
weight gain and/or obesity are known to increase
the risk of lymphedema after breast cancer treatment.
In the past, especially because of the limited availability
of high evidence-based studies that address lymphedema-
related exercises, patients were often advised to
avoid exercise for the affected extremity, to protect the
affected extremity, and to limit physical activity to reduce
the risk of lymphedema.[65] These recommendations
include some implementations such as avoidance
of certain medical procedures (such as blood pressure
measurement, injection, blood drawing), minimizing
applications such as wearing tight clothing or lifting
heavy items that will cause the extremity to become
trapped, avoiding the stressful activities of the affected
extremities, wearing compression garments during
travel and exercise [65] (Table 5). Generally, these prophylactic
recommendations may lead to anxiety and
fear about what individuals should be able to exercise
safely without causing lymphedema or exacerbating
the existing lymphedema, and how to protect the affected
extremity.[17,26]
Table 5: Patient control list for reducing lymphedema risk
The effect of physical activity and exercise on the
lymphatic system may vary according to the recommended
exercise. Studies in healthy subjects found that
the exercise regimen, which included dynamic muscle contractions, increased lymph flow in both the peripheral
lymphatic system collecting ducts and skeletal
muscles.[66-
In the literature, remedial, aerobic, strengthening,
stretching, other exercises (such as pilates, Tai Chi,
yoga) are recommended for lymphedema management
and control.[19,69]
Therapeutic (remedial) exercises; are a type of exercise
involving a specific group of repetitive movements
designed to promote recurrent muscle contractions on
the extremity with lymphedema. They include active,
rhythmic, repetitive and unresistant movements of the
extremity. It is stated that these exercises should be
combined with respiratory exercises.[19,70]
These exercises lightly compress the smooth muscles
of the walls of the lymph vessels with rhythmic
muscle contractions and relaxation by providing contractions,
as well as contractions of the smooth muscles
in the walls of the lymph vessels and when this externally
applied compression is sufficient, an internal
pumping mechanism occurs that increases lymphatic
flow along the pressure gradient, with the help of collateral
drainage pathways from existing lymphatic
channels.[19,70] The effect of aerobic exercises on the
lymphatic system is summarized in the following Figure
1.
Aerobic exercises; are exercises that bring large
muscle groups up to speed and increase the heart and
respiratory rate of individuals. These types of exercises
improve cardiovascular endurance by gradually increasing
heart and lung capacity.[19,70]
Strengthening exercises; are based on basis of imposing
burden on the muscles. The resistance created
by this exercise provides stimulation of the motor units
and contraction of most of the muscle fibers. Free
weights are used in these exercises. To prevent muscle
fatigue, it is recommended that these exercises should
be started with low weights, progressing slowly and
gradually.[19,70]
Stretching exercises; provide loosening of fibrous
tissue, regulation of body biomechanics, and stimulation
of lymph flow. These exercises minimize the complications
that reduce lymph flow, such as skin scars
and joint contractures and increase or maintain joint
range of motion by stretching muscles and connective
tissue.[19,70]
The Roles and Responsibilities of Nurses in
Lymphedema Prevention and Treatment
Nursing Interventions for Lymphedema Prevention
and Treatment
• Physical evaluation of the affected extremity in
terms of lymphedema by monitoring the patient at
appropriate intervals, measurement of the extremities
and comparison with the previous measurement
results, monitoring of the exercise program and maintenance of the individual"s home care in
the post-discharge period.[72-74]
As stated in the Regulation on the Amendment of
the Nursing Regulation published in the Official Gazette
dated April 19, 2011 with number 27910; nurses
have duties, powers and responsibilities, such as symptom
management and provision of support to improve
the quality of life for patients and their families, assessing
the individuals with holistic view, providing communication
and independent living skills necessary for
daily life process, teaching, supporting and monitoring
the individuals to improve their quality of life by improving
self care.[75]
As a result, as mentioned in the nursing regulation,
within the scope of the educational, supportive, rehabilitative
roles; nurses should be informed about lymphedema,
risk factors, symptoms, protective approaches
and management, inform individuals and their families,
have active role in preventing and reducing this
problem with appropriate nursing interventions.
Disclosure Statement
2. Lymphedema praecox; develops during puberty
shortly thereafter in most individuals.
3. Lymphedema tarda; occurs after the age of 35 [20,
After classification according to the etiology of lymphedema,
staging is necessary based on clinical findings.
[16,24] Staging allows an objective assessment to record
deviations from the normal state. At the same
time the staging system plays an essential role in planning
the appropriate medical intervention and evaluating
the effectiveness of the intervention.[16] Although
not yet a single staging system, most researchers use
the criteria set out in the International Society of Lymphology
(ISL) consensus report.[16,26]
In general, lymphedema risk factors are classified into
three categories: treatment, disease, and patient-related
factors (Table 3).
Different signs and symptoms may arise in the extremity
where lymphedema develops. These symptoms and
findings include following:
Sensation of heaviness and
• Pain or discomfort
• Restricted movement
• Feeling of weakness in the affected extremity
• Swelling in all or a specific region of the extremity
• Narrow clothing, underwear or jewellery
• Feeling of numbness and tingling on the affected
extremity.[8,19,40-42]
Anamnesis (patient history), physical examination,
limb circumference measurement, volumetric measurements,
imaging methods are used in the diagnosis
and assessment of lymphedema.[44]
Each patient with a risk of lymphedema or have lymphedema
should be assessed in terms of age, body mass
index, lifestyle, past medical history, health status;
etiology, duration, localization, prognosis of edema;
condition of the skin and tissues, presence of infection,
wounds or lymphorrhea; applied medical treatment,
effect of lymphedema on the quality of life and
the patient"s/family"s expectation from the treatment.
[26,40,44,45] This information acquired from the patient
and his/her family will be a helpful guide to health
staff on how to effectively treat the problem of lymphedema.[40]
In the physical examination, the condition of the skin
and tissues are considered using the methods of inspection
and palpation.
Measurements of the upper extremity circumference
could be performed from bone protrusions (ulnar stiloid,
olecranon, metacarpophalangeal joint), as well as
with equal spacing (2 cm, 4 cm, 5 cm or 10 cm) from
the anatomical point of the arm, such as the antecubital
fossa, to axillary. Lymphedema is clinically diagnosed
when a 2 cm difference or more in arm circumference
at least one anatomic point measured between the affected
and nonaffected limbs.[5,45] Circumference
measurements measurements are preferred because
they are simpler, lower cost and easier to use than volumetric
measurements
In volumetric measurements, the patient"s extremities
are immersed in a cylindrical container filled with water
and the amount of outflow is measured in mililiters.
The difference between the healthy extremity and the
affected extremity determines the amount of edema. A
difference of more than 200 ml between the arms or a
volume difference of 20% or more according to the normal
extremity is accepted as lymphedema.[46,48,49]
When the diagnosis of lymphedema is uncertain after
clinical evaluation and physical examination, or when
better prognostic factors are needed; imaging methods
such as lymphoscintigraphy, lymphangiography, ultrasonography
(USG), color doppler USG, lymphatic capillaryoscopy,
magnetic resonance imaging, computed
tomography, bioimpedance are utilized.[19,26,44,46]
Lymphedema can develop immediately after a month
or years, as it can occur immediately in a group at risk.
In some patients at risk, lymphedema never develops.
Lymphedema negatively affects functional capacity,
psychosocial well-being and quality of life.[50] Individuals
at risk for lymphedema should be careful in
their daily life activities throughout their life. The aims
of the lymphedema management are to prevent the
progression of the clinical picture and development of cellulitis and other infections, to reduce and maintain
the size of the extremities, to alleviate the disturbance
caused by excessive fluid and protein accumulation,
and to train the patient about self-management.[51]
Skin and nail care is an important part of CDT. Skin
healing and protective approaches are also important
in both phases of CDT. While phase-I focuses on the
repair and maintenance of damaged skin, it is important
to maintain skin care in phase-II.[58] The purposes of skin care in patients with lymphedema are to
control bacterial and fungal colonization, reduce microbial
colonization in skin folds, provide skin hydration
to prevent dryness and fissure formation, provide
patient comfort and reduce infection risk.[40,59]
Compression therapy is performed in three different
ways to facilitate the circulation of the lymph fluid.
These are compression bandages, compression garments
and compression devices.[3]
Compression bandages are systematic implementation
of various types of filling material and short stretch bandages.
Bandages are applied with moderate pressure in
the distal parts of the affected extremities/limbs and a
lower compression is applied by decreasing the pressure
toward the proximal parts. In the bandaged extremity,
the pressure on the interstitial area increases and the
flow of the lymph fluid is facilitated.[61,62] Bandages
also reduce the volume and help maintaing skin integrity
and protect the skin from trauma.[62] While
bandages are used 24 hours a day during the intensive
treatment phase; they are used in conjunction with
compression garments at nights. It is recommended
that compression bandages should be worn every day;
removed only when patients are asleep at night.[45,63]
Compression garments are often used in clinical practice
to manage symptoms of lymphedema and require
careful patient assessment, patient compliance and patient
monitoring by the trainer. The compression garment
should be tailor-made and apply 20-60 mmHg
pressure according to the severity of the lymphedema.
They should be replaced with the new one every three
to six months when they lose their elasticity.[2,63] It
is recommended that compression garments should be
worn daily, 24 hours a day.[2] Compression garments
should not be used in the presence of arterial insufficiency,
acute heart failure, extreme deformity of the limbs, skin ulceration, severe peripheral neuropathy
and lymphorrhea.[2,63]
Compression devices are also called pneumatic pumps.
Compression devices work by giving constant or intermittent
pressure to the extremity during an adjustable
time period.[5] The duration of treatment with compression
devices can last up to 30 minutes to several
hours depending on the severity of the lymphedema
and the condition of the patient.[3] Studies on the
physiological effects of these devices have shown that
they direct lymph fluid from distal to proximal.[5,16]
MLD is a massage-like technique that is applied not
only to the affected area of the body but also to the
lymph nodes in other areas for 30 to 60 minutes to provide
lymphatic flow.[64] It is performed by intermittently
applying light pressure directly to the superficial
lymph vessels below the skin. With MLD, the smooth
muscles surrounding the lymph vessels are mechanically
stimulated to provide more frequent contractions
of the muscles and thus the lymphatic flow rate and the
forward movement of the lymph fluid are increased.
The proximal part of the limb is always first drained
and then advanced to the distal parts.[5,45,46,49,62]
SLD is a simplified version of MLD. After the training,
it can be done by the patient or his/her relatives. It
shows its effect as it is in MLD.
• Leaving shoulder, neck, arms and hands freely during
application
• Applying the pressure with the inner surfaces of the
fingers and not using the fingertips when applying
pressure
• Being very light the applied pressure
• Firstly stretching the skin gently then slacking off
• Directing drainage to unaffected lymph nodes
• Not implementing in the presence of any infection
Physical activity and exercise are important components
in the control and prevention of cancer. Physical
activity and exercise therapies play an important role
in CDT by stimulating lymphatic system functions in
cancer patients, as well as by reducing fatigue, body fat,
anxiety and depression, and promoting cardiovascular
health, muscle strength and functional capacity. Physiologically,
exercise has the effect of increasing venous
and lymphatic rotation in the affected extremities by
activating skeletal muscles. The pumping activity that
the muscle makes, along with other supporting mechanisms,
directs these fluids towards the heart and provides
an uninterrupted circulation.[17,44]
Lymphedema is a problem that affects individuals"
lifestyles and functions, causes physical and psychosocial problems, affects their quality of life in a negative
way, and could be prevented or reduced by appropriate
nursing interventions.[71] Nurses, who are important
members of the healthcare team play a key role in helping
individuals take responsibility for their own lymphedema,
in the prevention, management and follow-up
of lymphedema. Nurses should identify the group of
patients at high risk for developing lymphedema, take
necessary precautions to protect from lymphedema,
intervene early by assessing lymphedema and inform the patients about their self-care.
• Assessment of the patient"s in preoperative and
postoperative period in terms of the risk of developing
lymphedema
• Performing routine extremity measurement to
evaluate the changes in the volume of the patient in pre-postoperative period and assessment the degree
of movement of the extremity
• Assessing the body weight of patient in pre-postoperative
period and calculating the body mass
index
• Not using the extremity on the side of the operation
side for any parenteral intervention and blood pressure
measurement
• Protecting the position of affected extremity during
the first 24 hours after surgery
• Initiating mild exercises to keep the patient"s hand
muscles and fingers function as far as possible 24
hours after surgery
• Monitoring of affected area after surgery in terms of
infection and lymphedema symptoms
• Performing of lymph drainage to ensure the continuity
of the lymph circulation in the affected area
and teaching to patient/his or her relatives after the
surgery
• Establishing an appropriate exercise program for
the patient after surgery and encouraging and supporting
the patient in this program adaptation
• Training patients/ his or her relatives about subjects
such as lymphedema, signs-symptoms of lymphedema,
points to consider when performing daily
living activities to prevent or reduce the risk of
lymphedema development, actions to be taken in
the event of lymphedema development, and so on
(see Table
The authors declare no conflicts of interest.
References
1) Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J,
Jemal A. Global Cancer Statistics, 2012. CA Cancer J
Clin 2015;65:87-108. Crossref
2) Harris SR, Hugi RM, Olivotto IA, Levine M. Clinical
practice guidelines for the care and treatment of breast
cancer. 11. Lymphedema. CMAJ 2001;164(2):191-9.
3) Morrell RM, Halyard MY, Schild SE, Ali MS, Gunderson
LL, Pockaj BA. Breast cancer-related lymphedema.
Mayo Clin Proc 2005;80(11):1480-4. Crossref
4) Baron RH. Surgical management of breast cancer. Semin
Oncol Nurs 2007;23(1):10-9. Crossref
5) Golshan M, Smith B. Prevention and management of
arm lymphedema in the patient with breast cancer. J
Support Oncol 2006;4(8):381-6.
6) Bicego D, Brown K, Ruddick M, Storey D, Wong
C, Harris SR. Exercise for women with or at risk
for breast cancer-related lymphedema. Phys Ther
2006;86(10):1398-405. Crossref
7) Mortimer PS, Bates DO, Brassington HD, Stanton
AWB, Strachan DP, Levick JR. The prevalence of arm
oedema following treatment for breast cancer. QJ Med
1996;89(5):377-80. Crossref
8) Petrek JA, Heelan MC. Incidence of breast carcinomarelated
lymphedema. Cancer 1998;83(S12B):2776-81.
9) Herd-Smith A, Russo A, Muraca MG, Del Turco MR,
Cardona G. Prognostic factors for lymphedema after
primary treatment of breast carcinoma. Cancer
2001;92(7):1783-7. Crossref
10) Petrek JA, Senie RT, Peters M, Rosen PP. Lymphedema
in a cohort of breast carcinoma survivors 20 years after
diagnosis. Cancer 2001;92(6):1368-77. Crossref
11) Tsai HJ, Hung HC, Yang JL, Huang CS, Tsauo JY. Could
Kinesio tape replace the bandage in decongestive lymphatic
therapy for breast-cancer-related lymphedema?
A pilot study. Support Care Cancer 2009;17(11):1353-60. Crossref
12) Clark B, Sitzia J, Harlow W. Incidence and risk of arm
oedema following treatment for breast cancer: a threeyear
follow-up study. QJM 2005;98(5):343-8. Crossref
13) Bani HA, Fasching PA, Lux MM, Rauh C, Willner M,
Eder I, et al. Lymphedema in breast cancer survivors:
assessment and information provision in a specialized
breast unit. Patient Educ Couns 2007;66(3):311-8. Crossref
14) Park JH, Lee WH, Chung HS. Incidence and risk
factors of breast cancer lymphoedema. J Clin Nurs
2008;17(11):1450-9. Crossref
15) Williams AF, Vadgama A, Franks PJ, Mortimer PS.
A randomized controlled crossover study of manual
lymphatic drainage therapy in women with breast
cancer-related lymphoedema. Eur J Cancer Care
(Engl) 2002;11(4):254-61.16. Tretbar LL, Morgan
CL, Byung-Boong L, Simonian SJ, Blondeau B.
Lymphedema. London: Springer; 2008.
17) Chang CJ, Cormier JN. Lymphedema interventions:
exercise, surgery, and compression devices. Semin
Oncol Nurs 2013;29(1):28-40. Crossref
18) Lasinski BB. Complete decongestive therapy for
treatment of lymphedema. Semin Oncol Nurs
2013;29(1):20-7. Crossref
19) International Lymphoedema Framework: An International
Perspective. International Consensus Best practice
for the management of lymphoedema. Skin Care
and Cellulitis/Erysipelas; 2006. p. 24-9.
20) Oremus M, Walker K, Dayes I, Raina P. Diagnosis and
treatment of secondary lymphedema. Rockville (MD):
Agency for Healthcare Research and Quality (US);
2010.
21) Ridner SH. Pathophysiology of lymphedema. Semin
Oncol Nurs 2013;29(1):4-11. Crossref
22) Gloviczki P. Handbook of venous disorders. Guidelines
of the American Venous Forum. London: Edward
Arnold; 2009.
23) Burns T, Breathnach S, Cox N, Griffiths C. Rook"s
Textbook of Dermatology. Oxford: Wiley-Blackwell;
2010. Crossref
24) Singh N. Radioisotopes-Applications in Bio-Medical Science. Intech Open Access Publisher; 2011. Crossref
25) Burgdorf WHC, Plewig G, Wolff HH, Landthaler M.
Braun-Falco"s Dermatology. Heidelberg: Springer;
2009. Crossref
26) Bernas M. Assessment and risk reduction in lymphedema.
Semin Oncol Nurs 2013;29(1):12-9. Crossref
27) International Society of Lymphology. The diagnosis
and treatment of peripheral lymphedema. Consensus
document of the International Society of Lymphology.
Lymphology 2003;36(2):84-91.
28) International Society of Lymphology. The diagnosis
and treatment of peripheral lymphedema. 2009 Concensus
Document of the International Society of Lymphology.
Lymphology 2009;42(2):51-60.
29) Lee BB, Bergan J, Rockson SG. Lymphedema: a concise
compendium of theory and practice. Springer Science
& Business Media; 2011. Crossref
30) Özaslan C, Kuru B. Lymphedema after treatment of
breast cancer. Am J of Surg 2004;187:69-72. Crossref
31) Shah C, Vicini FA. Breast cancer-related arm lymphedema:
incidence rates, diagnostic techniques, optimal
management and risk reduction strategies. Int J Radiat
Oncol Biol Phys 2011;81(4):907-14. Crossref
32) DiSipio T, Rye S, Newman B, Hayes S. Incidence of
unilateral arm lymphoedema after breast cancer: a
systematic review and meta-analysis. Lancet Oncol
2013;14(6):500-15. Crossref
33) Helyer LK, Varnic M, Le LW, Leong W, McCready
D. Obesity is a risk factor for developing postoperative
lymphedema in breast cancer patients. Breast J
2010;16(1):48-54. Crossref
34) Das N, Baumgartner RN, Riley EC, Pinkston CM,
Yang D, Baumgartner KB. Treatment-related risk factors
for arm lymphedema among long-term breast
cancer survivors. J Cancer Surviv 2015;9(3):422-30.
35) Deo SV, Ray S, Rath GK, Shukla NK, Kar M, Asthana
S, Raina V. Prevalence and risk factors for development
of lymphedema following breast cancer treatment.
Indian J Cancer 2004;41(1):8-12.
36) Ahmed RL, Thomas W, Yee D, Schmitz KH. Randomized
controlled trial of weight training and
lymphedema in breast cancer survivors. J Clin Oncol
2006;24(18):2765-72. Crossref
37) Meeske KA, Sullivan-Halley J, Smith AW, McTiernan
A, Baumgartner KB, Harlan LC, et al. Risk factors for
arm lymphedema following breast cancer diagnosis in
Black women and White women. Breast Cancer Res
Treat 2009;113(2):383-91. Crossref
38) Ahmed RL, Schmitz KH, Prizment AE, Folsom AR.
Risk factors for lymphedema in breast cancer survivors,
the Iowa Women"s Health Study. Breast Cancer
Res Treat 2011;130(3):981-91. Crossref
39) Paskett ED, Naughton MJ, McCoy TP, Case LD, Abbott
JM. The epidemiology of arm and hand swelling
in premenopausal breast cancer survivors. Cancer
Epidemiol Biomarkers Prev 2007;16(4):775-82. Crossref
40) Wanchai A, Beck M, Stewart BR, Armer JM. Management
of lymphedema for cancer patients with complex
needs. Semin Oncol Nurs 2013;29(1):61-5. Crossref
41) Shahpar H, Atieh A, Maryam A, Fatemeh HS, Massoome
N, Mandana E, et al. Risk factors of lymph
edema in breast cancer patients. Int J Breast Cancer
2013;1-7. Crossref
42) Müezzinler NE, Karayurt Ö. Investigation of Experiences
of Women Who Developed Lymphedema
Related to Breast Cancer Treatment. J Breast Health
2014;10:23-9. Crossref
43) Sackey H, Magnuson A, Sandelin K, Liljegren G, Bergkvist
L, Fülep Z, et al. Arm lymphoedema after axillary
surgery in women with invasive breast cancer. Br
J Surg 2014;101(4):390-97. Crossref
44) Maclellan RA, Greene AK. Lymphedema. Semin Pediatr
Surg 2014;23(4):191-7. Crossref
45) Gary DE. Lymphedema diagnosis and management. J
Am Acad Nurse Pract 2007;19(2):72-8. Crossref
46) Başaran S, Kozanoğlu E. Breast cancer related lymphedema
and conservative therapies. Türk Fiz Tıp Rehab
Derg 2009;55(1):30-5.
47) Földi E, Földi M. Lymphostatic Diseases. In: Földi, M.,
Földi, E. (Ed.), Földi"s Textbook of Lymphology for
Physicians and Lymphedema Therapists. 2nd edition.
Munich, Mosby-Elsevier; 2006. p. 223-317.
48) Szuba A, Rockson SG. Lymphedema: classification, diagnosis
and therapy. Vasc Med 1998;3(2):145-56.
49) Petrek JA, Pressman PI, Smith RA. Lymphedema: current
issues in research and management. CA Cancer J
Clin 2000;50(5):292-311. Crossref
50) Rodrick JR, Poage E, Wanchai A, Stewart BR, Cormier
JN, Armer JM. Complementary, alternative, and other
noncomplete decongestive therapy treatment methods
in the management of lymphedema: a systematic
search and review. PM R 2014;6(3):250-74. Crossref
51) Sayko O, Pezzin LE, Yen TW, Nattinger AB. Diagnosis
and treatment of lymphedema after breast cancer: a
population-based study. PM R 2013;5(11):915-23.
52) Cheville AL, McGarvey CL, Petrek JA, Russo SA, Taylor
ME, Thiadens SR. Lymphedema management. Semin
Radiat Oncol 2003;13(3):290-301. Crossref
53) Cancer Australia. Clinical Best Practice/Lymphoedema
Specialised treatment 2012. http://canceraustralia.
gov.au/clinical-best-practice/lymphoedema/
gp-guides-and-resources/specialised-treatment. (Accessed:
01.02.2015).
54) Lasinski BB, McKillip Thrift K, Squire D, Austin MK, Smith KM, et al. A systematic review of the evidence
for complete decongestive therapy in the treatment of
lymphedema from 2004 to 2011. PM R. 2012;4(8):580-
601. Crossref
55) Oremus M, Dayes I, Walker K, Raina P. Systematic
review: conservative treatments for secondary lymphedema.
BMC Cancer 2012;12(1):6. Crossref
56) Vignes S, Blanchard M, Arrault M, Porcher R. Intensive
complete decongestive physiotherapy for cancerrelated
upper-limb lymphedema: 11 days achieved
greater volume reduction than 4. Gynecol Oncol
2013;131(1):127-30. Crossref
57) Bernas MJ, Witte CL, Witte MH. The diagnosis and
treatment of peripheral lymphedema: draft revision
of the 1995 Consensus Document of the International
Society of Lymphology Executive Committee for discussion
at the September 3-7, 2001, XVIII International
Congress of Lymphology in Genoa, Italy. Lymphology
2001;34(2):84-91.
58) Asmussen PD, Strössenreuther RHK. Földi"s Textbook
of Lymphology for Physicians and Lymphedema Therapists.
Mosby-Elsevier; 2006.
59) Olszewski WL. Contractility patterns of normal and
pathologically changed human lymphatics. Ann N Y
Acad Sci 2002;979:52-63; discussion 76-9. Crossref
60) Zuther JE, Norton S. Lymphedema Management.
Stuttgart New York: Thieme; 2013. Crossref
61) Pain SJ, Purushotham AD. Lymphoedema following
surgery for breast cancer. Br J Surg 2000;87(9):1128-41. Crossref
62) Holcomb SS. Identification and treatment of different
types of lymphedema. Adv Skin Wound Care
2006;19(2):103-10. Crossref
63) Cheville AL. Current and future trends in lymphedema
management: implications for women"s health.
Phys Med Rehabil Clin N Am 2007;18(3):539-53.
64) Devoogdt N, Van Kampen M, Geraerts I, Coremans T,
Christiaens MR. Different physical treatment modalities
for lymphoedema developing after axillary lymph
node dissection for breast cancer: a review. Eur J Obstet
Gynecol Reprod Biol 2010;149(1):3-9. Crossref
65) McLaughlin SA. Lymphedema: Separating Fact From
Fiction. Oncology 2012;26(3):242-9.
66) Olszewski WL, Engeset A. Studies on the lymphatic
circulation of humans. In M. G. Johnston (Ed.), Experimental
Biology of the Lymphatic Circulation,
Amsterdam: Elsevier Science Publishers; 1985. p. 395-422.
67) Havas E, Parviainen T, Vuorela J, Toivanen J, Nikula T,
Vihko V. Lymph flow dynamics in exercising human
skeletal muscle as detected by scintography. J Physiol
1997;504 (Pt 1):233-9. Crossref
68) Havas E, Lehtonen M, Vuorela J, Parviainen T, Vihko
V. Albumin clearance from human skeletal muscle
during prolonged steady-state running. Exp Physiol
2000;85(6):863-8. Crossref
69) Johansson K. Is physiotherapy useful to the breast cancer
patient? Acta Oncol 2005;44(5):423-4. Crossref
70) Földi M, Földi E, Kubik S. Textbook of lymphology
for physicians and lymphedema therapists. Urgan &
Fischer Verlag (Elsevier); 2003.
71) Ahmed RL, Prizment A, Lazovich D, Schmitz KH,
Folsom AR. Lymphedema and quality of life in breast
cancer survivors: the Iowa Women"s Health Study. J
Clin Oncol 2008;26(35):5689-96. Crossref
72) Gürsoy AA. Meme kanseri tedavisine bağlı lenfödem
ve hemşirelik bakımı. Cumhuriyet Üniversitesi Hemşirelik Yüksekokulu Dergisi 2005;9(2):18-25.
73) Hull MM. Lymphedema in women treated for breast
cancer. Semin Oncol Nurs 2000;16(3):226-37. Crossref
74) Jennings-Sanders A, Kuo YF, Anderson ET, Freeman
JL. How do nurse case managers care for older
women with breast cancer? Oncol Nurs Forum
2005;32(3):625-32. Crossref
75) Hemşirelik Yönetmeliğinde Değişiklik Yapılmasına
Dair Yönetmelik (2011). T. C. Resmi Gazete, 27910, 19
Nisan 2011.